Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROCHLOROTHIAZIDE Cause Diplopia? 544 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 544 reports of Diplopia have been filed in association with HYDROCHLOROTHIAZIDE (Irbesartan and Hydrochlorothiazide). This represents 2.6% of all adverse event reports for HYDROCHLOROTHIAZIDE.

544
Reports of Diplopia with HYDROCHLOROTHIAZIDE
2.6%
of all HYDROCHLOROTHIAZIDE reports
178
Deaths
104
Hospitalizations

How Dangerous Is Diplopia From HYDROCHLOROTHIAZIDE?

Of the 544 reports, 178 (32.7%) resulted in death, 104 (19.1%) required hospitalization, and 91 (16.7%) were considered life-threatening.

Is Diplopia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE. However, 544 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROCHLOROTHIAZIDE Cause?

Hyponatraemia (2,138) Drug ineffective (1,889) Acute kidney injury (1,838) Nausea (1,536) Dyspnoea (1,521) Dizziness (1,469) Headache (1,419) Hypotension (1,347) Fall (1,323) Malaise (1,312)

What Other Drugs Cause Diplopia?

ESOMEPRAZOLE (585) SIMVASTATIN (560) PREGABALIN (556) BISOPROLOL (541) ADALIMUMAB (531) FINGOLIMOD (505) LEVOTHYROXINE (473) APIXABAN (471) ATORVASTATIN (396) NAPROXEN (388)

Which HYDROCHLOROTHIAZIDE Alternatives Have Lower Diplopia Risk?

HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\IRBESARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LISINOPRIL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LOSARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\METOPROLOL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\NEBIVOLOL

Related Pages

HYDROCHLOROTHIAZIDE Full Profile All Diplopia Reports All Drugs Causing Diplopia HYDROCHLOROTHIAZIDE Demographics